Holen Sie sich die Stockscreener-App
8.63
1.03%
-0.09
Schlusskurs vom Vortag:
$8.72
Offen:
$8.79
24-Stunden-Volumen:
26,981
Relative Volume:
0.34
Marktkapitalisierung:
$238.19M
Einnahmen:
$21.25M
Nettoeinkommen (Verlust:
$-16.05M
KGV:
-14.15
EPS:
-0.61
Netto-Cashflow:
$-17.14M
1W Leistung:
+2.19%
1M Leistung:
+2.74%
6M Leistung:
+38.52%
1J Leistung:
+30.56%
1-Tages-Spanne:
$8.41
$8.8247
1-Wochen-Bereich:
$8.28
$8.94
52-Wochen-Spanne:
$3.96
$9.30
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Firmenname
Fennec Pharmaceuticals Inc
Sektor
Branche
Telefon
(919) 636-4530
Adresse
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Vergleichen Sie FENC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.63 | 240.84M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-08 | Fortgesetzt | Craig Hallum | Buy |
| 2020-06-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Eingeleitet | Goldman | Buy |
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
What drives Fennec Pharmaceuticals Inc. stock pricePhenomenal wealth increase - PrintWeekIndia
Is Fennec Pharmaceuticals Inc. a good long term investmentSignificant capital appreciation - PrintWeekIndia
What analysts say about Fennec Pharmaceuticals Inc. stockUnrivaled growth potential - jammulinksnews.com
Fennec Pharmaceuticals Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
How To Trade (FENC) - news.stocktradersdaily.com
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
What makes Fennec Pharmaceuticals Inc. stock price move sharplyFree Elite Traders Group - Newser
(FENC) Long Term Investment Analysis - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSE:FRX) Reaches New 52-Week High – Still a Buy? - Defense World
Long Term Trading Analysis for (FENC) - news.stocktradersdaily.com
Bank of America Corp DE Has $226,000 Stock Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmac - GuruFocus
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharmaceuticals elects board members, shareholders approve proposals By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals elects board members, shareholders approve proposals - Investing.com
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting - TipRanks
Fennec Announces Results of Annual Meeting - TradingView
Northern Trust Corp Sells 2,976 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
FENC Meeting Scheduled in Toronto Hosted by Craig-Hallum | FENC Stock News - GuruFocus
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fennec Pharmaceuticals Inc-Aktie (FENC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A | Director |
Jul 07 '25 |
Sale |
8.71 |
1,119 |
9,746 |
54,792 |
| Raykov Rosty | Director |
Jul 03 '25 |
Sale |
8.61 |
10,000 |
86,100 |
60,670 |
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):